Prophylaxis of at risks persons with an ultrapotent SARS-CoV-2-neutralizing antibody Ghent University
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes COVID-19, has now spread all over the globe, infected millions, and already killed more than 200.000 people. Elderly people are most likely to develop severe disease and to die from COVID-19. The aim of this project is to have a manufacturable, cost-effective, ultrapotent SARS-CoV-2-neutralizing antibody ready for prophylactic use in the most vulnerable individuals ...